Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $10 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by Alere, Inc. (formerly, Inverness Medical Innovations, Inc.). Chembio markets its HIV STAT-PAK® line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio has developed a patented point-of-care test platform technology, the Dual Path Platform (DPP®) technology, which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP®. Headquartered in Medford, NY, with approximately 170 employees, Chembio is licensed by the U.S. Food and Drug Administration (FDA) as well as the U. S. Department of Agriculture (USDA), and is certified for the global market under the International Standards Organization (ISO) directive 13.485.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Cellectis AB, a subsidiary of Takara Holdings, Inc., is a Swedish company located in Gothenburg. The firm manufactures and distributes stem cell-related products. On September 04, 2014 Takara Bio, Inc. acquired Cellectis AB from Cellectis SA.

BioMerieux designs, develops, manufactures, and markets in vitro diagnostic systems for clinical and industrial applications. The company’s diagnostic systems consist of reagents and consumables used to conduct biological tests, for use in performing screening, diagnostic assistance, prognosis, and treatment monitoring; instruments, platforms, and autoanalyzers used for automated testing at high or low throughputs; software to process analyses and systems to interpret biological test results; and other related services such as the installation and maintenance of instruments, user training, and the audit of laboratory workflows. BioMerieux offers diagnostic systems for clinical applications including the diagnosis of infectious diseases, comprising HIV, tuberculosis, and respiratory diseases, as well as cardiovascular diseases and targeted cancers based on the analysis of biological samples such as blood, saliva, and urine; and for industrial applications including the analysis of microbiological manufacturing such as food, pharmaceuticals, and cosmetics. The company markets and sells its products through a network of distributors to private sector analysis laboratories, hospital laboratories, blood banks, and physician office laboratories; food, pharmaceutical, and cosmetics industries; and independent quality control laboratories. It has operations in Europe, the Middle East, Africa, North America, Asia-Pacific, and Latin America. BioMerieux were founded in 1963 and is headquartered in Marcy l’Etoile, France. It is a subsidiary of Institut Mérieux.

Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. Its products include endotoxin activity assay diagnostic and polymyxin b-hemoperfusion therapeutic device. The company was founded on July 29, 1991 and is headquartered in Toronto, Canada.

Dade Behring, Inc. provides clinical diagnostic services. The firm's solutions include consulting & real time solutions, customer service support and streamCARE. The company is located in Deerfield, IL.

Lpath, Inc. is the category leader in the discovery and development of monoclonal antibodies that target (neutralize) bioactive lipids. The study of lipids (called lipidomics) is an emerging field of research that has already identified dozens of bioactive lipids that contribute to disease, with the promise of hundreds more as funding in the area continues to accelerate. Once a disease-causing lipid is identified, however, the challenge becomes one of generating a compound that neutralizes the relevant bioactive lipid. With its ImmuneY2:tm: platform technology and robust patent estate, Lpath is uniquely positioned to meet such challenges and exploit these opportunities.

Nexus Dx, Inc. engages in the provision of of a near patient testing system and advanced diagnostic solution. Its offers point-of-care (POC) immunoassay, IB10 analyzer system, and tests for established critical care parameters. The company was founded on January 16, 2009 and is headquartered in San Diego, CA.

Medical Analysis Systems, Inc. provides blood derivative diagnostic agency services. The company is headquartered in Fremont, CA.

Shanghai Lingchao Biotechnology Co., Ltd., established on 2008-01-08, The scope of business includes engaging in technology development in the field of biological product technology,technical consulting,Technical Services,technology transfer,chemical reagent(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Pharmaceutical Intermediates(In addition to drugs),Wholesale of instruments and meters,retail,Maintenance of instruments and meters,Raw material of animal serum(Except for medical use)processing(Limited to branch operations),Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Apollo Endosurgery develops medical devices for the diagnosis and treatment of gastrointestinal diseases. The company’s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo’s products include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon. Apollo Endosurgery was founded upon the initial work of the Apollo Group, an international think tank of world-renowned gastroenterologists and surgeons from five leading universities (Mayo Clinic, Johns Hopkins, Medical University of South Carolina, University of Texas Medical Branch-Galveston and Chinese University-Hong Kong.) Disappointed with the pace of innovation in therapeutic flexible endoscopy, the Group assembled in 1998 (Timeline) with the goal to advance the new discipline; their specific focus was the use of long, flexible instruments deployed through a natural orifice in order to diagnose and potentially treat gastrointestinal disorders.

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Particle Cloud Technology (Beijing) Co., Ltd., established on 2016-12-06, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Economic and Trade Consulting;market survey;Undertake exhibition and display activities;Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Sales of medical devicesI,IIkind.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Jilin Shuangzheng Medical Technology Co., Ltd., established on 2013-03-27, Business scope includes biomedical technology research and development and consulting services,technical consulting,technology transfer;medical instruments,Green facilities,computer,Sales and maintenance of printers and consumables;Medical device production;import and export trade(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Beijing Shengkunkangru Medical Instrument Co., Ltd, established on 2015-07-29, Business scope includes sales of medical devices,Packaging Materials,Chemical Products,clothing,daily necessities,cosmetic,crafts,stationery,sporting goods,electronic product,hardware,AC,building materials,knitted goods,communication equipment,computer,Software and Auxiliary Equipment;Import and export,Technology Import and Export,Agent import and export;commission agent(except auction);technology development,technical consulting,Technical Services,Technology Promotion;Investment Advisory,Travel advisory,Trade Consulting,Educational Consulting,Planning creative services;Organize cultural and artistic exchange activities;design,make,acting,Place an ad;Professional design service;Conference Services;Undertake the exhibition;market survey;asset Management;business management;Warehousing Services;Conference Services;lease,Repair medical equipment;sell food,medicine;road freight transport.(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,road freight transport,Sales of pharmaceuticals and items subject to legal approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.

Biochem Group concentrates on the socioeconomic aspects of medicine, health care, food safety, and military medicine. It provides technology platforms for areas like big data and artificial intelligence Internet applications, software and hardware system integration, physical therapy and rehabilitation, spectrometry, detection, blood coagulation detection, and more.

Developer of proprietary blood-based biomarker tests to transform the management of chronic respiratory diseases. The company is focused on addressing the unmet need for tools to provide a real-time, biological assessment of a patient’s disease state. ProterixBio's products will enable health care providers to better manage their patients and avoid unnecessary hospitalizations, leading to improved outcomes and reduced health care costs. It was founded in 2002 and headquartered in Billerica, Massachusetts.

Supplies in vitro diagnostics products and services

Anyou Medical Technology (Wuhan) Co., Ltd., established on 2013-03-20, Business scope includes licensed projects:Radio and television program production and management;Internet culture management;Information network dissemination of audio-visual programs;Import and export;Import and export agency;Technology Import and Export;Class III medical device business;Production of Class II Medical Devices;Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Network technology service;Health Consulting Services(Does not include medical services);data processing services;Information Consulting Service(Not including licensing information consulting services);Digital cultural and creative content application services;advertisement making;Professional Design Services;Film Production Services;Digital Content Production Services(Does not include publishing);Film and television art props setting service;Camera and Video Production Services;Culture and Entertainment Broker Services;Personal Internet Live Streaming Service(Need to record);Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Retailing of computer software, hardware and auxiliary equipment;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Production of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)